Germany's Merck KGaA said it is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical company that specializes in rare diseases and cancer.

As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...

Reaching this vision of Michigan by 2065 demands bold leadership, clear goals, strategic investments and persistence. Amid global disruptions, political divides, natural disasters, and growing ...

Merck KGaA, the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and ...

A growing coalition of donors, donor-conceived people, and recipient parents are fighting for change in an industry wrought with ethical issues.

Subscribe to the Wake Up, cleveland.com’s free morning newsletter, delivered to your inbox weekdays at 5:30 a.m. Should Ohio ...

Things to do in Boston, Feb. 10-16, 2025, including sex trivia night, Boston movies at The Wang Theatre, and Bloody Mary ...